Treatment of cartilage defects of the knee: expanding on the existing algorithm
- PMID: 24157464
- DOI: 10.1097/JSM.0000000000000004
Treatment of cartilage defects of the knee: expanding on the existing algorithm
Abstract
Objective: The purpose of this review is to survey the literature regarding factors used in determining a course of surgical treatment for symptomatic cartilage lesions of the knee to determine which factors affect treatment outcomes and should be incorporated in the treatment algorithm.
Methods: A systematic review was performed using PubMed, Cochrane Review, and SportDiscus databases for studies investigating factors affecting cartilage lesion treatment and outcomes. Inclusion criteria were clinical and basic science studies in English, on human or animal specimens that focus on factors affecting the initiation, progression, and treatment of focal knee chondral defects.
Results: Twenty-seven studies examining 1450 human (1416 in vivo; 34 cadaveric) and 90 animal subjects met inclusion criteria. Female sex and higher body mass index (BMI) significantly predicted cartilage loss rates and recovery after microfracture (MFx) and autologous matrix-induced chondrogenesis. Defect size and location significantly predicted treatment outcomes. Sizes >2 to 4 cm demonstrated worse outcomes after MFx treatment. Defect size did not consistently affect autologous chondrocyte implantation or osteochondral autograft transplantation outcomes. Intra-articular lesion location was related to intralesional subchondral bone contact and MFx outcome. Corrected patellofemoral and tibiofemoral alignment improved clinical outcome when realignment procedures were done concurrently with cartilage repair.
Conclusions: Choice of the appropriate repair technique for focal knee cartilage defects is multifactorial. A treatment algorithm should consider frequently used factors such as defect size, location, knee alignment, and patient demand. However, patient sex and BMI could also be considered. Patient age was not significantly associated with clinical outcome.
Similar articles
-
Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation.Health Technol Assess. 2005 Dec;9(47):iii-iv, ix-x, 1-82. doi: 10.3310/hta9470. Health Technol Assess. 2005. PMID: 16336842
-
Autologous chondrocyte implantation: a systematic review.J Bone Joint Surg Am. 2010 Sep 15;92(12):2220-33. doi: 10.2106/JBJS.J.00049. J Bone Joint Surg Am. 2010. PMID: 20844166 Free PMC article.
-
Autologous chondrocyte implantation in the knee: systematic review and economic evaluation.Health Technol Assess. 2017 Feb;21(6):1-294. doi: 10.3310/hta21060. Health Technol Assess. 2017. PMID: 28244303 Free PMC article.
-
Third-Generation Autologous Chondrocyte Implantation (Cells Cultured Within Collagen Membrane) Is Superior to Microfracture for Focal Chondral Defects of the Knee Joint: Systematic Review and Meta-analysis.Arthroscopy. 2022 Aug;38(8):2579-2586. doi: 10.1016/j.arthro.2022.02.011. Epub 2022 Mar 10. Arthroscopy. 2022. PMID: 35283221
-
Treatment of chondral defects in the athlete's knee.Arthroscopy. 2010 Jun;26(6):841-52. doi: 10.1016/j.arthro.2009.12.030. Arthroscopy. 2010. PMID: 20511044
Cited by
-
The Biomimetics of Mg2+-Concentration-Resolved Microenvironment for Bone and Cartilage Repairing Materials Design.Biomimetics (Basel). 2022 Dec 5;7(4):227. doi: 10.3390/biomimetics7040227. Biomimetics (Basel). 2022. PMID: 36546928 Free PMC article.
-
Cartilage defect location and stiffness predispose the tibiofemoral joint to aberrant loading conditions during stance phase of gait.PLoS One. 2018 Oct 16;13(10):e0205842. doi: 10.1371/journal.pone.0205842. eCollection 2018. PLoS One. 2018. PMID: 30325946 Free PMC article.
-
Matrix-induced autologous chondrocyte implantation for the treatment of chondral defects of the knees in Chinese patients.Drug Des Devel Ther. 2014 Dec 5;8:2439-48. doi: 10.2147/DDDT.S71356. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25525334 Free PMC article.
-
Use of MACI (Autologous Cultured Chondrocytes on Porcine Collagen Membrane) in the United States: Expanded Experience over 5,000 Cases.Cartilage. 2025 Apr 9:19476035251319404. doi: 10.1177/19476035251319404. Online ahead of print. Cartilage. 2025. PMID: 40202752 Free PMC article.
-
Focal cartilage defects in the knee - a randomized controlled trial comparing autologous chondrocyte implantation with arthroscopic debridement.BMC Musculoskelet Disord. 2016 Mar 8;17:117. doi: 10.1186/s12891-016-0969-z. BMC Musculoskelet Disord. 2016. PMID: 26956476 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous